92 related articles for article (PubMed ID: 1498512)
1. The urinary acylcarnitine profile in three cases of transient hyperammonemia of the newborn.
Sakuma T; Sugiyama N; Wada Y
Acta Paediatr; 1992 May; 81(5):436-8. PubMed ID: 1498512
[No Abstract] [Full Text] [Related]
2. Alteration of urinary carnitine profile induced by benzoate administration.
Sakuma T
Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
[TBL] [Abstract][Full Text] [Related]
3. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
Matsuda I; Ohtani Y; Ninomiya N
J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
[TBL] [Abstract][Full Text] [Related]
4. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
[TBL] [Abstract][Full Text] [Related]
5. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
Ohtani Y; Ohyanagi K; Yamamoto S; Matsuda I
J Pediatr; 1988 Mar; 112(3):409-14. PubMed ID: 3346778
[TBL] [Abstract][Full Text] [Related]
6. Analytical method for urinary glutarylcarnitine, acetylcarnitine and propionylcarnitine with a carboxylic acid analyser and a reversed-phase column.
Kidouchi K; Sugiyama N; Morishita H; Wada Y; Nagai S; Sakakibara J
J Chromatogr; 1987 Dec; 423():297-303. PubMed ID: 3443662
[No Abstract] [Full Text] [Related]
7. Urinary excretion of carnitine and its derivatives in newborns.
Cederblad G; Finnström O; Mårtensson J
Biochem Med; 1982 Apr; 27(2):260-5. PubMed ID: 7082329
[No Abstract] [Full Text] [Related]
8. Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis.
Hoppel CL; Genuth SM
Am J Physiol; 1982 Aug; 243(2):E168-72. PubMed ID: 6810706
[TBL] [Abstract][Full Text] [Related]
9. Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment.
Michalak A; Qureshi IA
Biochem Med Metab Biol; 1990 Apr; 43(2):163-74. PubMed ID: 2346672
[TBL] [Abstract][Full Text] [Related]
10. Neonatal hyperammonemia associated with carnitine deficiency.
Nagao M; Tsuchiyama A; Mori T; Agatsuma Y; Oyanagi K
Tohoku J Exp Med; 1989 Aug; 158(4):317-23. PubMed ID: 2588261
[TBL] [Abstract][Full Text] [Related]
11. Identification of benzoylcarnitine in the urine of a patient of hyperammonemia.
Sakuma T; Asai K; Ichiki T; Sugiyama N; Kidouchi K; Wada Y
Tohoku J Exp Med; 1989 Oct; 159(2):147-51. PubMed ID: 2609332
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.
Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL; Rossi TM; Lebenthal E
J Pediatr; 1989 Oct; 115(4):577-82. PubMed ID: 2795349
[TBL] [Abstract][Full Text] [Related]
13. Alterations of urinary acetylcarnitine in valproate-treated rats: the effect of L-carnitine supplementation.
Murakami K; Sugimoto T; Nishida N; Woo M; Araki A; Kobayashi Y
J Child Neurol; 1992 Oct; 7(4):404-7. PubMed ID: 1469250
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic separation of acylcarnitines following derivatization with 4'-bromophenacyl trifluoromethanesulfonate.
Minkler PE; Ingalls ST; Hoppel CL
Anal Biochem; 1990 Feb; 185(1):29-35. PubMed ID: 2344045
[TBL] [Abstract][Full Text] [Related]
15. Neonatal hyperammonemia caused by a defect of carnitine-acylcarnitine translocase.
Ogier de Baulny H; Slama A; Touati G; Turnbull DM; Pourfarzam M; Brivet M
J Pediatr; 1995 Nov; 127(5):723-8. PubMed ID: 7472823
[TBL] [Abstract][Full Text] [Related]
16. Carnitine metabolism in the vitamin B-12-deficient rat.
Brass EP; Stabler SP
Biochem J; 1988 Oct; 255(1):153-9. PubMed ID: 3196310
[TBL] [Abstract][Full Text] [Related]
17. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.
Morand R; Todesco L; Donzelli M; Fischer-Barnicol D; Mullen PJ; Krähenbühl S
Ther Drug Monit; 2012 Aug; 34(4):406-14. PubMed ID: 22743351
[TBL] [Abstract][Full Text] [Related]
18. Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
Röschinger W; Muntau AC; Duran M; Dorland L; IJlst L; Wanders RJ; Roscher AA
Clin Chim Acta; 2000 Aug; 298(1-2):55-68. PubMed ID: 10876004
[TBL] [Abstract][Full Text] [Related]
19. Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia: significance of acetylcarnitine determination to estimate the proper carnitine dose.
Itoh T; Ito T; Ohba S; Sugiyama N; Mizuguchi K; Yamaguchi S; Kidouchi K
Tohoku J Exp Med; 1996 Jun; 179(2):101-9. PubMed ID: 8875766
[TBL] [Abstract][Full Text] [Related]
20. Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state.
Hiatt WR; Regensteiner JG; Wolfel EE; Ruff L; Brass EP
J Clin Invest; 1989 Oct; 84(4):1167-73. PubMed ID: 2794054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
